StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$161.52+0.73 (+0.45%)

Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –

Novartis Employee LTIR by Year

Employee LTIR (×)

Novartis Employee LTIR: 0.12× in FY2025, down 7.7% from a year earlier.

Latest, FY2025
0.12
Period ended Dec 31, 2025
Change on a year earlier
-7.7%
0.13 in FY2024
History
3 years
Since FY2023
Sources
2
Documents cited below

Where the FY2025 figure comes from

“| Employees | 0.12 | 0.13 | ∆ |”

Source: Novartis Official IR / Sustainability Report — novartis-esg-data-summary-2025.pdf ↗

Reported in ESG Data Summary 2025.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Novartis Employee LTIR (×), annual FY2023–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/hse-ltir-employees

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.